Atrium Therapeutics, Inc.
RNA
$13.19
$0.413.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 267.85M | -- | -- | ||
| Total Receivables | 15.00M | 100.00K | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 2.58M | 1.54M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 138.00K | 1.21M | -- | ||
| Total Current Assets | 285.57M | 2.85M | -- | ||
|
|
|||||
| Total Current Assets | 285.57M | 2.85M | -- | ||
| Net Property, Plant & Equipment | 6.38M | 5.51M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 415.00K | -- | -- | ||
| Total Assets | 292.36M | 8.35M | -- | ||
|
|
|||||
| Total Accounts Payable | 807.00K | 4.40M | -- | ||
| Total Accrued Expenses | 9.07M | 8.69M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 2.68M | 3.67M | -- | ||
| Total Finance Division Other Current Liabilities | 9.34M | 25.04M | -- | ||
| Total Other Current Liabilities | 9.34M | 25.04M | -- | ||
| Total Current Liabilities | 21.91M | 41.80M | -- | ||
|
|
|||||
| Total Current Liabilities | 21.91M | 41.80M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 36.35M | 29.27M | -- | ||
| Total Liabilities | 58.26M | 71.07M | -- | ||
|
|
|||||
| Common Stock & APIC | 221.98M | -62.71M | -- | ||
| Retained Earnings | 12.13M | -- | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 234.10M | -62.71M | -61.11M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 234.10M | -62.71M | -61.11M | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 234.10M | -62.71M | -61.11M | ||
|
|
|||||